How to conquer tardive dyskinesia: could pharmacogenetics and therapy drug monitoring be useful tools?

Skip to the main content

Liječnički vjesnik, Vol. 145 No. Supp 8, 2023.

Meeting abstract

https://doi.org/10.26800/LV-145-supl8-34

How to conquer tardive dyskinesia: could pharmacogenetics and therapy drug monitoring be useful tools?

Dino Žujić
Nada Božina
Mila Lovrić
Lana Ganoci
Maja Živković

Full text: english pdf 221 Kb

page 43-43

downloads: 185

APA 6th Edition

Žujić, D., Božina, N., Lovrić, M., Ganoci, L. & Živković, M. (2023). How to conquer tardive dyskinesia: could pharmacogenetics and therapy drug monitoring be useful tools?. Liječnički vjesnik, 145 (Supp 8), 43-43. https://doi.org/10.26800/LV-145-supl8-34

MLA 8th Edition

Žujić, Dino, et al. "How to conquer tardive dyskinesia: could pharmacogenetics and therapy drug monitoring be useful tools?." Liječnički vjesnik, vol. 145, no. Supp 8, 2023, pp. 43-43. https://doi.org/10.26800/LV-145-supl8-34. Accessed 24 Nov. 2024.

Chicago 17th Edition

Žujić, Dino, Nada Božina, Mila Lovrić, Lana Ganoci and Maja Živković. "How to conquer tardive dyskinesia: could pharmacogenetics and therapy drug monitoring be useful tools?." Liječnički vjesnik 145, no. Supp 8 (2023): 43-43. https://doi.org/10.26800/LV-145-supl8-34

Harvard

Žujić, D., et al. (2023). 'How to conquer tardive dyskinesia: could pharmacogenetics and therapy drug monitoring be useful tools?', Liječnički vjesnik, 145(Supp 8), pp. 43-43. https://doi.org/10.26800/LV-145-supl8-34

Vancouver

Žujić D, Božina N, Lovrić M, Ganoci L, Živković M. How to conquer tardive dyskinesia: could pharmacogenetics and therapy drug monitoring be useful tools?. Liječnički vjesnik [Internet]. 2023 [cited 2024 November 24];145(Supp 8):43-43. https://doi.org/10.26800/LV-145-supl8-34

IEEE

D. Žujić, N. Božina, M. Lovrić, L. Ganoci and M. Živković, "How to conquer tardive dyskinesia: could pharmacogenetics and therapy drug monitoring be useful tools?", Liječnički vjesnik, vol.145, no. Supp 8, pp. 43-43, 2023. [Online]. https://doi.org/10.26800/LV-145-supl8-34

Abstract

Tardive dyskinesia is a neurological disorder characterized by involuntary, repetitive mo-vements of the face, tongue, and limbs, which may result from a long-term use of antip-sychotics.

Keywords

clozapine, paliperidone palmitate, pharmacogenetics, tardive dyskinesia, TDM

Hrčak ID:

314460

URI

https://hrcak.srce.hr/314460

Publication date:

22.2.2024.

Visits: 479 *